0.32
0.47%
-0.0015
Handel nachbörslich:
.31
-0.01
-3.13%
Finanzdaten der In 8 Bio Inc-Aktie (INAB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
125.15%
0.083
|
-0.33 | - | - | 0.33 |
Operating Expenses
|
13.78%
8.645
|
7.598 | 7.169 | 7.715 | 7.855 |
Benefits Costs and Expenses |
8.645
|
- | 7.169 | 7.715 | 7.855 |
Costs And Expenses |
8.645
|
- | 7.169 | 7.715 | 7.855 |
Operating Income/Loss |
8.00%
-8.562
|
-7.928 | -7.169 | -7.715 | -7.525 |
Income/Loss From Continuing Operations Before Tax |
35.81%
-8.562
|
-13.34 | -7.169 | -7.715 | -7.525 |
Income/Loss From Continuing Operations After Tax |
12.69%
-8.562
|
-7.598 | -7.169 | -7.715 | -7.525 |
Net Income/Loss
|
12.69%
-8.562
|
-7.598 | -7.169 | -7.715 | -7.525 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,623%
43.29
|
1.5897 | 31.55 | 28.47 | 24.73 |
Diluted Average Shares |
2,623%
43.29
|
1.5897 | 31.55 | 28.47 | 24.73 |
Basic Earnings Per Share |
4.76%
-0.20
|
-0.21 | -0.23 | -0.27 | -0.30 |
Diluted Earnings Per Share |
4.76%
-0.20
|
-0.21 | -0.23 | -0.27 | -0.30 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):